BioCentury
ARTICLE | Company News

Electrofect AS, Boehringer Ingelheim GmbH International deal

February 28, 2000 8:00 AM UTC

Boehringer received a non-exclusive license to use Electrofect's electroporation technology to promote uptake of DNA into cells in the field of oncology. ...